Sodium Polystyrene Sulfonate
14 NDCs across 7 manufacturers|13 Generic,1 Brand
Sodium Polystyrene Sulfonate is used to treat hyperkalemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Dec 8, 1982. In 2024, Medicare Part D spent $3 million on Sodium Polystyrene Sulfonate across 51,000 claims for 29,000 beneficiaries.
Sodium Polystyrene Sulfonate is available as 14 NDCs from 7 manufacturers (13 generic, 1 brand), with NADAC prices from $0.09 to $0.53 per GM — the most expensive product costs about 5.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
14
13G / 1B
Manufacturers
7
competing in market
Price Spread
$0.09 – $0.53
per GM, 11 of 14 NDCs
7d Activity
avg -1.3% WoW · of 14 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
7 manufacturers producing SODIUM POLYSTYRENE SULFONATE(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SODIUM POLYSTYRENE SULF POWDER | $0.5292 per GM | — |
SODIUM POLYSTYRENE SULF POWDER | $0.4713 per GM | +2.20% |
SODIUM POLYSTYRENE SULF POWDER | $0.4713 per GM | +2.20% |
SODIUM POLYSTYRENE SULF POWDER | $0.4713 per GM | +2.20% |
SODIUM POLYSTYRENE SULF POWDER | $0.4713 per GM | +2.20% |
SPS 15 GM/60 ML SUSPENSION | $0.4366 per ML | +0.44% |
SPS 15 GM/60 ML SUSPENSION | $0.3851 per ML | — |
KIONEX 15 GM/60 ML SUSPENSION | $0.3016 per ML | — |
SODIUM POLYSTYRENE SULF POWDER | $0.1530 per GM | -1.27% |
SODIUM POLYSTYRENE SULF POWDER | $0.1530 per GM | -1.27% |
SODIUM POLYSTYRENE SULF POWDER | $0.1530 per GM | -1.27% |
SODIUM POLYSTYRENE SULF POWDER | $0.0949 per GM | -6.52% |
SODIUM POLYSTYRENE SULF POWDER | $0.0949 per GM | -6.52% |
SODIUM POLYSTYRENE SULF POWDER | $0.0949 per GM | -6.52% |
Frequently Asked Questions
What is Sodium Polystyrene Sulfonate used to treat?
Sodium Polystyrene Sulfonate is used to treat hyperkalemia, per the National Library of Medicine's MED-RT classification.
When did Sodium Polystyrene Sulfonate become available as a generic?
FDA approved the first generic Sodium Polystyrene Sulfonate (ANDA) on Dec 8, 1982.
How much does Medicare spend on Sodium Polystyrene Sulfonate?
In 2024, Medicare Part D spent $3 million on Sodium Polystyrene Sulfonate across 51,000 claims for 29,000 beneficiaries.
How many Sodium Polystyrene Sulfonate products are on the market?
The Sodium Polystyrene Sulfonate drug market contains 14 NDCs from 7 manufacturers — 13 generic and 1 brand product.
What is the price range for Sodium Polystyrene Sulfonate?
NADAC reference prices for Sodium Polystyrene Sulfonate range from $0.0949 to $0.5292 per GM — the most expensive product costs about 5.6× the cheapest. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Sodium Polystyrene Sulfonate?
7 manufacturers list Sodium Polystyrene Sulfonate in NADAC. Ranked by number of NDCs, the largest are Sunrise Pharmaceutical Inc. (3), CMP Pharma, Inc. (3), KVK-Tech Inc. (2), Epic Pharma LLC (2), Chartwell RX LLC (2).
How has the price of Sodium Polystyrene Sulfonate changed recently?
Over the past 7 days, 5 Sodium Polystyrene Sulfonate NDCs rose and 6 fell, with a market-wide average change of -1.3%.